169 related articles for article (PubMed ID: 1826928)
1. Central nervous actions of serotonin and a serotonin1A receptor agonist: cardiovascular excitation at low doses.
Dedeoğlu A; Fisher LA
J Pharmacol Exp Ther; 1991 Apr; 257(1):425-32. PubMed ID: 1826928
[TBL] [Abstract][Full Text] [Related]
2. Hypotensive effects of 5-HT1A receptor agonists on the ventrolateral medullary pressor area in dogs.
Dabiré H; Laubie M; Schmitt H
J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S61-7. PubMed ID: 1702488
[TBL] [Abstract][Full Text] [Related]
3. Influence of urapidil and 8-OH-DPAT on brain 5-HT turnover and blood pressure in rats.
Valenta B; Kotai E; Weisz E; Singer EA
J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S68-74. PubMed ID: 1702489
[TBL] [Abstract][Full Text] [Related]
4. Hypotensive action of 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT) in spontaneously hypertensive rats.
Martin GE; Lis EV
Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):251-61. PubMed ID: 3159366
[TBL] [Abstract][Full Text] [Related]
5. Involvement of 5-hydroxytryptamine1A receptors in the modulation of micturition reflexes in the anesthetized rat.
Lecci A; Giuliani S; Santicioli P; Maggi CA
J Pharmacol Exp Ther; 1992 Jul; 262(1):181-9. PubMed ID: 1352548
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
Chaouloff F; Jeanrenaud B
J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
[TBL] [Abstract][Full Text] [Related]
7. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
[TBL] [Abstract][Full Text] [Related]
8. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat.
Deckert V; Chaouloff F; Richer C; Elghozi JL
Arch Int Pharmacodyn Ther; 1990; 306():114-29. PubMed ID: 1981665
[TBL] [Abstract][Full Text] [Related]
9. Involvement of 5-HT1A receptors in blood pressure reduction by 8-OH-DPAT and urapidil in cats.
Sanders KH; Beller KD; Kolassa N
J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S86-93. PubMed ID: 1702492
[TBL] [Abstract][Full Text] [Related]
10. Estrogen increases the bradycardia elicited by central administration of the serotonin1A agonist 8-OH-DPAT in conscious rats.
Alper RH; Schmitz TM
Brain Res; 1996 Apr; 716(1-2):224-8. PubMed ID: 8738244
[TBL] [Abstract][Full Text] [Related]
11. Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat.
Gradin K; Pettersson A; Hedner T; Persson B
J Neural Transm; 1985; 62(3-4):305-19. PubMed ID: 3161997
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
Björk L; Cornfield LJ; Nelson DL; Hillver SE; Andén NE; Lewander T; Hacksell U
J Pharmacol Exp Ther; 1991 Jul; 258(1):58-65. PubMed ID: 1830099
[TBL] [Abstract][Full Text] [Related]
13. Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
Gillis RA; Hill KJ; Kirby JS; Quest JA; Hamosh P; Norman WP; Kellar KJ
J Pharmacol Exp Ther; 1989 Feb; 248(2):851-7. PubMed ID: 2521902
[TBL] [Abstract][Full Text] [Related]
14. 5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat.
Bervoets K; Rivet JM; Millan MJ
J Pharmacol Exp Ther; 1993 Jan; 264(1):95-104. PubMed ID: 8423555
[TBL] [Abstract][Full Text] [Related]
15. Serotonin-induced reduction of the calcium-dependent plateau in frog dorsal root ganglion cells is blocked by serotonergic agents acting at 5-hydroxytryptamine1A sites.
Marszalec W; Scroggs RS; Anderson EG
J Pharmacol Exp Ther; 1988 Nov; 247(2):399-404. PubMed ID: 2972829
[TBL] [Abstract][Full Text] [Related]
16. Functional topography of brain serotonergic pathways in the rat.
Hillegaart V
Acta Physiol Scand Suppl; 1991; 598():1-54. PubMed ID: 1832809
[TBL] [Abstract][Full Text] [Related]
17. [Multiple [3H]8-hydroxy-2-(di-n-propylamino)-tetralin binding sites in rat brain: modulation by GTP and cations].
Yokota N; Yamawaki S; Hayakawa H; Yoshida R; Sarai K
Yakubutsu Seishin Kodo; 1989 Jun; 9(2):197-206. PubMed ID: 2530729
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
Dreteler GH; Wouters W; Saxena PR
Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis.
Fozard JR; Mir AK; Middlemiss DN
J Cardiovasc Pharmacol; 1987 Mar; 9(3):328-47. PubMed ID: 2437400
[TBL] [Abstract][Full Text] [Related]
20. Pressor effects following microinjection of 5-HT1A receptor agonists into the raphe obscurus of the anaesthetized rat.
Dreteler GH; Wouters W; Saxena PR; Ramage AG
Br J Pharmacol; 1991 Feb; 102(2):317-22. PubMed ID: 1673069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
